[go: up one dir, main page]

IL89082A0 - Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system - Google Patents

Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system

Info

Publication number
IL89082A0
IL89082A0 IL89082A IL8908289A IL89082A0 IL 89082 A0 IL89082 A0 IL 89082A0 IL 89082 A IL89082 A IL 89082A IL 8908289 A IL8908289 A IL 8908289A IL 89082 A0 IL89082 A0 IL 89082A0
Authority
IL
Israel
Prior art keywords
prophylaxis
disorders
compounds
treatment
nervous system
Prior art date
Application number
IL89082A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL89082A0 publication Critical patent/IL89082A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL89082A 1988-01-27 1989-01-26 Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system IL89082A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3802303 1988-01-27
DE3802760 1988-01-30
DE3813819 1988-04-22

Publications (1)

Publication Number Publication Date
IL89082A0 true IL89082A0 (en) 1989-08-15

Family

ID=27197111

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89082A IL89082A0 (en) 1988-01-27 1989-01-26 Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system

Country Status (12)

Country Link
US (1) US4999370A (xx)
EP (1) EP0331609A3 (xx)
JP (1) JPH01246222A (xx)
KR (1) KR890011599A (xx)
CN (1) CN1038096A (xx)
AU (1) AU615252B2 (xx)
DK (1) DK33989A (xx)
FI (1) FI890370A (xx)
IL (1) IL89082A0 (xx)
MA (1) MA21480A1 (xx)
NO (1) NO890330L (xx)
TN (1) TNSN89009A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
US5491241A (en) * 1993-10-18 1996-02-13 Eli Lilly And Company Bicyclic intermediates for excitatory amino acid receptor antagonists
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
CN1047384C (zh) * 1994-07-28 1999-12-15 北京大学 雷米普利的合成方法
US6610497B1 (en) * 1997-12-11 2003-08-26 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3151690A1 (de) * 1981-12-29 1983-07-07 Hoechst Ag, 6230 Frankfurt "neue derivate bicyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung"
DE3333454A1 (de) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern
DE3333455A1 (de) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung n-alkylierter dipeptide und deren estern
DE3431541A1 (de) * 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
DE3610391A1 (de) * 1986-03-27 1987-10-08 Hoechst Ag Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen
DE3639879A1 (de) * 1986-11-21 1988-06-01 Hoechst Ag Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren, zwischenprodukte dieses verfahrens sowie ein verfahren zu deren herstellung
DE3641451A1 (de) * 1986-12-04 1988-06-16 Hoechst Ag Derivate bicyclischer aminocarbonsaeuren, verfahren und zwischenprodukte zu deren herstellung sowie deren verwendung
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
DK33989A (da) 1989-07-28
CN1038096A (zh) 1989-12-20
TNSN89009A1 (fr) 1991-02-04
EP0331609A2 (de) 1989-09-06
AU615252B2 (en) 1991-09-26
NO890330L (no) 1989-07-28
US4999370A (en) 1991-03-12
DK33989D0 (da) 1989-01-26
JPH01246222A (ja) 1989-10-02
FI890370A (fi) 1989-07-28
MA21480A1 (fr) 1989-10-01
AU2884489A (en) 1989-07-27
NO890330D0 (no) 1989-01-26
KR890011599A (ko) 1989-08-21
FI890370A0 (fi) 1989-01-25
EP0331609A3 (de) 1992-07-01

Similar Documents

Publication Publication Date Title
EP0326034A3 (en) Combination for the treatment of nervous cells and fibers illnesses and disorders
GB2096465B (en) Hook for use with a rod for the treatment of spinal disorders
EP0727212A3 (en) Substituted phenylpyrimidine derivatives, for the treatment or prevention of CNS diseases
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
HK19496A (en) Use of 1,2,2,3,3-penta-fluoropropane
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
EP0479025A3 (en) Device for the treatment of non-circular surfaces of work-pieces
EP0275668A3 (en) Use of ketone derivatives in the treatment of cognitive disorders
EP0297555A3 (en) Modified chlorinated polypropylene, process for producing the same and use thereof
IL89082A0 (en) Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
EP0233762A3 (en) Use of aromatic diamines for the treatment of angina, and diamines therefor
DE3879535D1 (xx)
JPS6440456A (en) Substituted n-benzoyl-n'-2,5-dihalo-4- perfluoroalkoxyphenylurea, manufacture and use for vermicide
ZA886249B (en) Use of a compound for the treatment of sleep disorders and depression
ZA89574B (en) Compounds with a psychotropic action,agents containing them,and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
GB8715914D0 (en) Treatment of cerabral disorders
EP0583136A3 (en) Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
GB2195532B (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
EP0518484A3 (en) 1,4-benzodiazepines condesed with 5- and 6-membered heterocyclic rings to treat anxiety, pain, pupil constriction, withdrawal-syndrome or oncologic disorders
ZA893606B (en) Use of diazepinones for treating disorders of the microcirculation
GB8828185D0 (en) Improved medicine for treatment & prevention of stress & nervous disorders
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.